Pharmaceuticals, Biotechnology and Life Sciences
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer…
LONDON–(BUSINESS WIRE)–#Research–The global bronchiectasis drugs market is expected to post a CAGR close to 5% during the period 2019-2023, according…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#FamilialALS—Apic Bio, Inc., an innovative gene therapy company developing novel treatment options for patients with rare genetic diseases,…
WASHINGTON & MALVERN, Pa.–(BUSINESS WIRE)–#AMR–The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and…
LONDON–(BUSINESS WIRE)–#MarketIntelligence–SpendEdge, a leading provider of procurement market intelligence solutions, has announced the launch of their latest newsletter on the…
– Focus on clinical tool development to advance new treatments for neurobehavioral disorders – SAN FRANCISCO–(BUSINESS WIRE)–BlackThorn Therapeutics, Inc., a clinical-stage,…
BROOKLINE, Mass. & SHEFFIELD, United Kingdom–(BUSINESS WIRE)–Policy Analysis Inc. (PAI) and BresMed, two leading health-economics and outcomes research consultancies, are…
IMFINZI is the only immunotherapy approved to treat patients in this curative-intent setting following chemoradiation therapy WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today…
Biopharma executive brings successful track record of business and scientific leadership to Disarm’s development of disease-modifying therapeutics for patients with…
-Application supported by positive results from two global Phase 3 studies in people with CF ages 12 and older with…